Integral membrane proteins that recognize extracellular nucleotides were defined in 1976 and termed purinergic receptors [1] [2] [3] . Two families of purinergic receptors have since been established: ligand-gated P2X receptor ion channels 4 and G-protein coupled P2Y receptors 5 . P2X receptors are found throughout eukaryotes 6 ; in humans, they are expressed in a wide variety of cells and modulate processes as diverse as platelet activation, smooth muscle contraction, synaptic transmission, nociception, inflammation, hearing and taste 7, 8 , making P2X receptors important pharmacological targets 9 . The seven mammalian P2X receptor subtypes, denoted P2X 1 -P2X 7 , form homotrimeric and heterotrimeric complexes 4, 10, 11 . All subunits share a common topology containing intracellular termini, two transmembrane helices forming the ion channel, and a large extracellular domain containing the orthosteric ATP binding site 11, 12 . Whereas all P2X receptors are non-selective cation channels that are permeable to Na + and Ca 2+ and activated by ATP 13 , the pharmacology of receptor subtypes varies with respect to sensitivity to ATP analogue agonists and to small molecule antagonists. Thus, although 2′ -3′ -O-(2,4,6,-trinitrophenyl) adenosine 5′ -triphosphate (TNP-ATP) is the prototypical nanomolar-affinity antagonist of P2X 1,3 receptors, it binds 1,000-fold less tightly to P2X 2,4,7 receptors 9, 14 . The kinetics of ion channel gating also vary by subtype, with P2X 2,4,5,7 receptors showing slow and incomplete desensitization and P2X 1,3 receptors undergoing rapid and nearly complete desensitization 15, 16 . Membrane-proximal regions within the cytoplasmic termini play important roles in receptor desensitization [17] [18] [19] [20] [21] [22] [23] [24] [25] , but the detailed molecular mechanism of desensitization is unknown. Mechanisms that have been proposed are similar to the 'hinged lid' or 'ball and chain' models described for voltage-gated sodium and shaker potassium channels, respectively, with a distinct but unidentified desensitization gate 21, 26 . No structure of a P2X receptor in the desensitized state has been published, to our knowledge, and currently available structures of the zebrafish P2X 4 receptor (zfP2X 4 ) in the apo and open state conformations do not visualize cytoplasmic residues [27] [28] [29] . There is also concern that the available structure of zfP2X 4 bound to ATP 27 may not represent a physiological state because the truncated crystallization construct, which lacks both terminal domains, might distort the pore architecture 12, [30] [31] [32] . The mechanisms by which antagonists inhibit ion flow through P2X receptors remain elusive. A recent NMR study suggested that TNP-ATP inhibits activation by closing the extracellular fenestrations to ion access, rather than by stabilizing a closed-pore conformation 33 . To understand the molecular mechanisms of activation and antagonism of P2X receptors, we crystallized the human P2X 3 (hP2X 3 ) receptor in an apo/resting state, an agonist-bound/openpore state, an agonist-bound/closed-pore/desensitized state, and two antagonist-bound/closed states.
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Crystallization and structure determination
The hP2X 3 crystallization construct spans residues D6-T364 and is defined as hP2X 3 -MFC. It binds ATP with a dissociation constant (K d ) of 2.8 nM and has wild-type gating properties, as shown by scintillation proximity assays (SPA) 34 and two-electrode voltage clamp (TEVC; Extended Data Fig. 1a, b) , respectively. Notably, hP2X 3 -MFC demonstrates fast desensitization kinetics, the hallmark of homotrimeric P2X 3 receptors 35, 36 . Three rat P2X 2 -specific amino acid substitutions 21 were made at homologous residues in the N terminus of hP2X 3 to generate hP2X 3 -MFC-T13P/S15V/V16I (or hP2X 3 -MFC slow ), a construct with similar affinity (K d = 3.3 nM) for ATP (Extended Data Fig. 1c ) but with slow and incomplete desensitization (Extended Data  Fig. 1d ). The structure of the ATP-bound/open-pore state (Fig. 1a-c ) was obtained using hP2X 3 -MFC slow whereas hP2X 3 -MFC was used to determine the structure of the ATP-bound/closed-pore/desensitized state ( Fig. 1d-f) .
We further crystallized hP2X 3 -MFC slow in an apo/resting state ( Fig. 1g-i ) and in complex with two high-affinity P2X 3 ATP from detergent-solubilized hP2X 3 -MFC slow (Extended Data Fig. 1e-g ). Prolonged application of ATP to oocytes expressing hP2X 3 -MFC slow resulted in a residual current that was blocked by the competitive antagonists, suggesting that a fraction of these receptors did not desensitize (Extended Data Fig. 1h, i) . The hP2X 3 structures were refined to good crystallographic statistics and stereochemistry (Extended Data Table 1 ).
Overall architecture
The hP2X 3 structures follow the iconic trimeric P2X receptor architecture [27] [28] [29] , possessing a large hydrophilic extracellular domain, six α -helices forming the transmembrane domain, and intracellular termini (Fig. 1) . The shape of each protomer resembles that of a dolphin 27, 29 (Extended Data Fig. 2a ). The open state structure of hP2X 3 contains ATP in the ligand-binding pocket and an open pore (Fig. 1a-c) whereas the desensitized state structure has ATP in the pocket but a closed pore (Fig. 1d-f) . Although the extracellular domains and binding pockets of the desensitized and open states of hP2X 3 are similar, there are striking differences in the transmembrane domains and at the gates (Extended Data Fig. 3 ). Both hP2X 3 structures have transmembrane domains that are of sufficient length to cross a lipid bilayer, and the desensitized state structure has a pore architecture not previously observed for any P2X structure. The open state structure of hP2X 3 visualizes cytoplasmic residues that were truncated in the open state structure of zfP2X 4 (ref. 27 ) (Extended Data Fig. 2b ) and forms a domain termed the 'cytoplasmic cap' (Fig. 1a, c) .
The apo structure of hP2X 3 has an empty ligand-binding pocket and a closed pore (Fig. 1g-i ). An alignment to the apo structure of zfP2X 4 (ref. 29 ) reveals several unique features of the hP2X 3 apo structure, including a more complete transmembrane domain, different residues defining the pore constriction, and a Mg 2+ ion bound in the head domain (Extended Data Fig. 2c) . Comparison between the hP2X 3 structures and previously published zfP2X 4 structures emphasizes the longer transmembrane domains and the cytoplasmic domain of hP2X 3 (Extended Data Fig. 2b-d ). In the antagonist-bound state, the competitive antagonists TNP-ATP and A-317491 occupy the orthosteric ligand-binding pocket and the ion channel pore is closed and nearly identical to the apo/resting state (Extended Data Fig. 4 ).
Ion channel pore
To determine the functional state of each hP2X 3 structure, we analysed the conformation of the ion channel pore, together with alterations in the size and shape of cavities, vestibules and fenestrations throughout the receptor (Extended Data Fig. 3a, b) . Transmembrane helix 2 (TM2) lines the pore lumen, with residues I323, V326, T330, and V334 facing the pore 27, 29, 39 (Fig. 1c, f, i) . I323 defines the extracellular boundary of the gate in the apo state (pore radius 0.3 Å), whereas T330 defines the cytoplasmic boundary of the gate (pore radius 0.7 Å) (Extended Data Fig. 3b, c) . A third residue, V326, also contributes to the pore occlusion. These openings are too narrow to pass dehydrated Na + ions 40 and define the ion channel as closed (Fig. 1h, i) . The solventaccessible surface, dimensions, and residues lining the gate for both antagonist-bound structures are similar to those of the apo state structure, demonstrating that these competitive antagonists stabilize an apo/resting-like state of the receptor (Extended Data Fig. 4c-f) .
The open state structure of hP2X 3 has a continuous pore through the transmembrane domain with a minimum radius of 3.2 Å (Extended Data Fig. 3c ), which is large enough to pass partially hydrated Na + ions 41 and defines the ion channel gate as open (Fig. 1b, c) . Compared to the apo structure, I323 and V326 in the open state structure have been translated upward towards the extracellular surface and rotated outward, away from the pore's centre, to open the pore. T330, which defined the cytoplasmic boundary of the closed gate in the apo state, now defines the narrowest region of the pore in the open state. In hP2X 3 , T330 and S331 are the only hydrophilic residues lining the middle of the pore. For the rat P2X 2 receptor, a threonine residue at the equivalent position to T330 of hP2X 3 has been implicated in ion selectivity 42 , suggesting that T330 might interact with permeating cations. A single residue, V334, defines the constriction site of the desensitized state with a pore radius of 1.5 Å, too narrow to pass hydrated Na + ions (Fig. 1e, f and Extended Data Fig. 3c) . From the open to the desensitized states, V334 translates upward towards the extracellular surface and rotates inward to block the pore. To ensure the density in the pocket was truly ATP, we soaked the crystals with an ATP derivative, the P2X 3 agonist 2-(methylthio)adenosine 5′ -triphosphate (2-methylthio-ATP), and collected native and anomalous sulfur diffraction data (Extended Data Tables 1, 2 ). These soaked crystals retained the same receptor and pore structures but had a density in the binding pocket consistent with 2-methylthio-ATP, confirmed through the anomalous signal of the sulfur atom, providing evidence that the structure represents an agonist-bound/closed-pore/desensitized state (Extended Data Fig. 5 ).
Channel opening
Comparing the apo and open state structures of hP2X 3 demonstrates the extensive structural differences between these two conformational states, emphasizing the role of the 'cytoplasmic cap' in stabilizing the open state (Fig. 2a, b) . The cytoplasmic cap includes elements of secondary structure from both termini, including two sequential β -strands from the N terminus and a β -strand from the C terminus ( Fig. 2c and Extended Data Fig. 2a ). The tertiary structure of the cytoplasmic cap is defined by a network of three β -sheets that sit beneath the transmembrane domain, capping the cytoplasmic surface of the pore. The C-terminal β -strand of each protomer interacts with the N-terminal β -strands of each of the other two protomers to form a small β -sheet (Fig. 2c, d ). Each of the three β -sheets incorporates one β -strand from each of the three protomers, illustrating how domain swapping knits receptor subunits together on the cytoplasmic side of the membrane. The cytoplasmic cap is observed only in the ATP-bound open state structure, suggesting that the cap-forming elements are flexible and disordered in the apo state. Indeed, the three mutations that slow desensitization and were used to capture the open state of hP2X 3 provide main chain conformational rigidity and make key hydrophobic interactions that stabilize the structure of the cap (Fig. 2c, d ). Because these three substitutions are derived from the equivalent wild-type residues in the slowly desensitizing P2X 2 receptor, we suggest that the transient formation and stability of the cytoplasmic cap have a central role in P2X receptor gating and provide a structural scaffold for the open state that is likely to be disassembled in the apo and desensitized states.
ATP binding induces cleft closure between the head and dorsal fin domains while pushing the left flipper domain outward 27, 43 . These structural rearrangements are transmitted to the lower body, resulting in an outward flexing movement of the β 1, β 9, β 11 and β 14 strands. Because the β 1 and β 14 strands are directly coupled to the TM1 and TM2 helices, respectively (Extended Data Fig. 2a and Fig. 2a, b) , their outward flexing pulls on the extracellular portion of the transmembrane domains, causing the helices to expand outward and thereby opening the pore 27, 44 . Views from the extracellular side of the membrane, comparing the pore in the apo and open states, show the molecular basis of channel opening ( Fig. 2e-g ). When the lower body flexes and pulls on TM2, the helix rotates counterclockwise by ~ 15°. This outward rotation of TM2 promotes the translation of I323, the residue defining the extracellular gate of the apo state, upward by 6.3 Å towards the extracellular surface and reorients it away from the pore centre. The residue that defines the cytoplasmic gate of the apo state, T330, also moves upward by 5.3 Å and rotates away from the pore centre ( Fig. 2e-g ).
In zfP2X 4 , the movement of TM2 to open the channel was described as a purely rigid-body transformation 27 . For hP2X 3 , however, in addition to a rigid-body translation, there is a transition in TM2 from an α -helix to a 3 10 -helix centred within the sequence G333-V334-G335 (Fig. 2h) . The change in helical pitch allows movements of TM2 associated with channel opening and desensitization. We suggest that the formation of the cytoplasmic cap fixes the cytoplasmic portion of TM2 in place, forcing the helix to 'stretch' to a 3 10 conformation and thus stabilizing pore opening.
Channel desensitization
The transmembrane domains and pore architecture differ between the desensitized and open states at the cytoplasmic surface (Figs 2b, 3a) . During the transition to the desensitized state, the cytoplasmic portion of TM2 rotates by about 9° and the short 3 10 -helix formed in the open state reverts to an α -helix (Fig. 3b, c) , resulting in the upward translation towards the extracellular surface (4.4 Å) and inward rotation of V334. This movement in all three protomers closes the pore with V334 redefining a constriction site deeper in the membrane bilayer than the constriction site for the apo state (Fig. 3b, d and Extended Data Fig. 3c ).
The transition of TM2 to an ideal helix to close the pore in the desensitized state is not the reverse of the conformational change that opened the pore. The formation of the 3 10 -helix occurred as a result of stretching of the top half of TM2 upward towards the extracellular surface while its cytoplasmic surface was essentially fixed in place, anchored by the cytoplasmic cap. However, the transition from the open to the desensitized state reverts TM2 to an ideal helix by 'recoiling' the cytoplasmic half of the helix upward. The return of the cytoplasmic half of TM2 to an α -helix resembles the recoiling of a spring. For this recoil movement to occur, the cytoplasmic cap must break or become destabilized to release the 'anchor' and initiate desensitization.
The N terminus in the desensitized state is directed away from the pore, in the opposite direction of the backbone in the open state, suggesting that the structure of cytoplasmic residues differs between these two conformations (Fig. 3e) . This finding supports a model in which a transient cytoplasmic cap forms in the open state but ruptures during receptor desensitization. Notably, P2X receptors have a conserved N-terminal glycine 21 (G24 in P2X 3 ) and many subtypes, including hP2X 3 , have a glycine in the C terminus (G349 in hP2X 3 ) that could act as a hinge 45, 46 and provide the flexibility necessary to allow such dynamic conformational changes between functional states (Fig. 3e) , as well as the conformational flexibility necessary to 'reset' the receptor to the apo state (Extended Data Fig. 6 ).
Molecular basis of competitive antagonism
We determined the structure of hP2X 3 bound to representatives of two classes of P2X receptor competitive antagonists, TNP-ATP 14, 37 and A-317491 (ref. 38) . Both ATP and the antagonists occupy the orthosteric ligand-binding pocket, located at the interface between two protomers (Fig. 4 and Extended Data Fig. 7a-f) . The most striking difference between ATP and the competitive antagonists is deeper penetration of the latter into the binding cleft. While ATP adopts a U-shape, both TNP-ATP and A-317491 bind in a Y-shape, with the trinitrophenyl moiety of TNP-ATP and the phenoxy-benzyl moiety of A-317491 acting as the 'trunk' (Fig. 4) .
In the binding pocket, TNP-ATP adopts a different orientation from ATP. For ATP, the C 2 and C 3 carbons of the ribose group and the γ -phosphate point up, away from the cleft of the binding pocket, whereas for TNP-ATP, these atoms point down, facing into the cleft (Fig. 4d, e and Extended Data Fig. 7g ). These differences change how a number of side chain residues interact with the phosphate moieties. For example, K65 makes an ionic interaction with the γ -phosphate of ATP but with the α -phosphate of TNP-ATP. As a result of the different ligand poses, the ribose group of TNP-ATP sits deeper into the cleft of the binding pocket made by the 'left flipper' of protomer A and the 'dorsal fin' of protomer B. The trunk in both TNP-ATP and A-317491 forms hydrophobic interactions with F174, but ATP does not sit deep enough to interact with this residue. By more deeply occupying the space in the cleft between protomers, TNP-ATP and A-317491 prevent the ATP-induced upward movement of the dorsal fin of protomer B to close the binding cleft, precluding the conformational changes necessary for channel opening. TNP-ATP is the prototypical antagonist at P2X 1,3 receptors but binds substantially less tightly to P2X 2,4,7 receptors 9,14 . TNP-ATP makes important interactions with K65, D158, T172, F174, N279, R281, and K299 (Fig. 4e ). D158 and F174 are not conserved among all P2X family members but both are present in P2X 1 , 3 , suggesting that the subtype specificity of TNP-ATP is mediated, in part, through these residues.
The apo structure of hP2X 3 and both antagonist structures contain a Mg 2+ ion in the head domain, near the ligand-binding pocket (Extended Data Fig. 7h and Fig. 4e, f) , in a different region from that previously predicted 47 . Anomalous difference Fourier maps derived from crystals grown in MnCl 2 instead of MgCl 2 support the conclusion that the density feature is a Mg 2+ ion (Extended Data Fig. 8a, b and Extended Data Table 2 ). Because of the proximity of Mg 2+ to the ATP binding site, we investigated whether Mg 2+ could influence ATP binding affinity, as it has been shown to modulate recovery of receptors from desensitization 48 . However, the presence of Mg 2+ does not alter the affinity of hP2X 3 for ATP (Extended Data Fig. 8c ).
Ion access and permeation
On the basis of the P2X 4 receptor structure 29 , we suggested that ions enter the channel pore from the extracellular milieu via three lateral fenestrations located directly above the transmembrane domains at the extracellular vestibule 49, 50 (Extended Data Fig. 3a, b) . To investigate how ions enter the channel and identify monovalent cation binding sites, we grew apo hP2X 3 -MFC slow in the presence of CsCl instead of NaCl and probed for anomalous scattering from Cs + ions. An anomalous signal was present in a cavity made by the extracellular vestibule, consistent with Na + ions entering through the lateral fenestrations (Fig. 5a , b and Extended Data Table 2 ).
The egress of ions from the pore of the hP2X 3 open state structure to the cytoplasm cannot occur along the threefold axis of the receptor because the orifice along this axis is too small (Extended Data Fig. 3c) . However, the cytoplasmic cap and TM2 helices from adjacent protomers form the borders of a triangular-shaped cytoplasmic fenestration, apparently within the boundary of the lipid membrane, that could represent a path of ion egress (Fig. 2c) . To test whether these fenestrations are plausible routes for ion egress we carried out molecular dynamic simulations using the open state of the receptor in a 1-palmitoyl-2-ol eoyl-sn-glycero-3-phosphocholine (POPC) lipid bilayer (Fig. 5a, c, d ). Hydration patterns in the transmembrane region reveal the putative pathway for ions. Water molecules pass through the open pore but do not exit from the bottom surface of the cytoplasmic cap. Instead, water exits the protein lumen through the cytoplasmic fenestrations (Fig. 5c) . Polar lipid head groups line the protein at the fenestrations and probably assist in water permeation. Independent Na + permeation events were observed through all three cytoplasmic fenestrations, suggesting that Na + ions enter via lateral extracellular fenestrations and egress through lateral cytoplasmic fenestrations (Fig. 5d) .
Gating cycle
Initiation of P2X receptor gating begins with the binding of ATP between two subunits, induction of cleft closure and, through structural coupling, an outward flexing of the lower body domain ( Supplementary  Videos 1-3 and Fig. 6 ). Because the β -sheets of the lower body domain are directly coupled to the transmembrane helices, their outward movement pulls on the extracellular portions of the transmembrane domains. This conformational change at the extracellular domain induces three major structural changes in the transmembrane and cytoplasmic domains during the transition from the apo to the open state: a counterclockwise rotation of TM2 to open the pore in an irislike movement; a change in helical pitch for a turn of TM2 from an α -helix to a 3 10 -helix; and formation of the cytoplasmic cap, which anchors the cytoplasmic surfaces of the transmembrane domains, and provides cytoplasmic fenestrations through which ions exit the pore.
Transition from the open to the desensitized state has two major features: the cytoplasmic cap unfolds or disassembles, and TM2 recoils upward, reverting the short stretch of 3 10 -helix to an α -helix and allowing the pore to close at a new constriction site, located deeper within the membrane bilayer. In this way, the transition of TM2 from the open state to the desensitized state resembles the recoiling of a spring that has been stretched from above and subsequently released from below. We refer to this as the 'helical recoil' model of receptor desensitization and suggest that the structure of the cytoplasmic cap stabilizes the open state, with its stability tuning the rate and extent of receptor desensitization. The role of the cytoplasmic cap in receptor function is not surprising because residues in both termini of P2X receptors have long been implicated in modulating desensitization 22, 23, 25 .
Conclusion
The structures of all iconic functional states of hP2X 3 receptor highlight how the ion pathway changes from the apo to open to desensitized states. We visualize the full-length transmembrane domains and characterize the structural role of the intracellular residues in P2X receptor gating. Our structures reveal how the cytoplasmic cap anchors the transmembrane domain to allow a change in helical pitch in TM2 upon channel opening and provides a phospholipid-lined pathway for ions to laterally exit the pore. We hypothesize that the cytoplasmic cap undergoes a folding-unfolding transition during channel gating and its stability sets the rate of receptor desensitization, with the fastdesensitizing P2X receptor subtypes having a relatively less stable cap domain and the slow and incompletely desensitizing receptor subtypes having a more stable cap domain. The competitive antagonists TNP-ATP and A-317491 bind to the orthosteric site and stabilize the apo state of the receptor. The structures of hP2X 3 represent each of the major conformational states in the receptor gating cycle and illuminate the molecular mechanisms behind P2X receptor activation, desensitization and inhibition.
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MethOdS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Receptor constructs. The initial construct for the hP2X 3 receptor was engineered based on the crystallization construct for the open state structure of zfP2X 4 (Δ P2X 4 -C) 27 and had 19 residues removed from the N terminus and 49 residues removed from the C terminus (hP2X 3 -Δ N19Δ C49). Although this receptor construct bound ATP with nanomolar affinity in radio-ligand binding assays, it showed no functional gating properties, as assessed by two-electrode voltage clamp experiments. Therefore, we systematically added residues back to both the N and C termini to obtain a functional hP2X 3 construct. The return of 14 residues to the N terminus and 16 residues to the C terminus yielded hP2X 3 -Δ N5Δ C33, referred to as hP2X 3 -MFC (minimal functional construct). To increase the likelihood of obtaining an open state conformation of the receptor, three rat P2X 2 -specific amino acid substitutions (P19, V21 and I22) were made at the corresponding positions in the N terminus of human P2X 3 to confer the slowly desensitizing receptor phenotype 21 , referred to as hP2X3-Δ N5Δ C33-T13P/S15V/ V16I or hP2X 3 -MFC slow . Expression, membrane preparation and protein purification. The hP2X 3 -MFC and hP2X 3 -MFC slow proteins were expressed in HEK293S GNTI − (GNTI is also known as MGAT1) cells as N-terminal EGFP fusions with an octa-histidine affinity tag and a thrombin cleavage sequence using baculovirus-mediated gene transduction of mammalian cells 51 . HEK293S GNTI − cells in suspension were grown to a density of 3.0 × 10 6 ml −1 and then infected by P2 BacMam virus. After growth at 37 °C for 16 h, sodium butyrate was added to 10 mM final concentration and the cells were shifted to 30 °C for an additional 72 h. Cells were then harvested, washed with PBS buffer and resuspended in TBS (50 mM Tris, pH 8.0 and 150 mM NaCl). The cells were broken by sonication in the presence of protease inhibitors (1 mM PMSF, 0.05 mg/ml aprotinin, 2 μ g/ml pepstatin A, and 2 μ g/ml leupeptin) and the membrane fraction was isolated by ultracentrifugation.
Pelleted membranes were resuspended in TBS buffer + 15% glycerol, homogenized and solubilized in 40 mM dodecyl-β -d-maltopyranoside, referred to as C12M. The solubilized fraction was isolated by ultra-centrifugation and incubated with TALON resin at 4 °C for 1-2 h. After the resin was packed into an XK-16 column, the column was washed with 12 column volumes of buffer (TBS buffer plus 1 mM C12M, 30 mM imidazole and 5% glycerol) before being eluted with buffer containing 250 mM imidazole, pH 8.0. Fractions were pooled together and the pH was lowered to 6.5 by the addition of 500 mM MES, pH 6.5. Protein was then digested with thrombin (1:25, w/w) and Endo H (1:3, w/w) at room temperature for ~ 16 h. The digested protein was concentrated and clarified by ultracentrifugation. The supernatant was injected onto a Superdex 200 10/300 GL column pre-equilibrated with 20 mM HEPES, pH 7.0, 100 mM NaCl, and 0.5 mM C12M to isolate trimeric receptors using size-exclusion chromatography (SEC). Monodispersed fractions were collected and hP2X 3 was concentrated to 2-3 mg/ml before crystallization. For crystallization experiments designed to locate Na + binding sites using the anomalous signal from Cs + ions, SEC was performed with 100 mM CsCl instead of 100 mM NaCl.
For apo state and antagonist-bound structures, membranes were subjected to a dialysis step before purification in order to ensure removal of endogenous ATP. To do this, cell membranes were homogenized and transferred into an 8-10 kDa molecular mass cut-off cellulose ester dialysis tubing and dialysed in 150× volume of buffer containing 50 mM Tris pH 9.5, 1 M NaCl, 5% glycerol with buffer exchanges occurring once or twice per day over the course of six days. Dialysed membranes were then solubilized and the protein was purified, as described above. Crystallization and structure determination. All crystals were obtained with protein at 2-3 mg/ml and set up at 4 °C in the hanging drop vapour diffusion method by mixing 1:1 (v/v) ratio with reservoir buffer. Crystals typically grew after 2-3 weeks. Crystallization of apo state. Initial experiments to crystallize hP2X 3 in the apo state did not include a high salt dialysis step during purification. Structures obtained without dialysis contained a strong density in the binding pocket, consistent with the size, shape, and orientation of ATP, and thus were in fact not apo states of the receptor. We attributed the observed density to endogenous, cellular ATP, which presumably bound during cell lysis and stayed bound throughout the purification. Introducing a high salt dialysis step (see above) allowed the removal of endogenous ATP and the structure determination of a true apo state of the receptor. Purified hP2X 3 -MFC slow obtained from dialysed membranes was set up with reservoir buffer containing 25% PEG 400, 100 mM MES, pH 6.85, and 50 mM MgCl 2 . Crystals were cryo-protected by increasing the concentration of PEG 400 to 36% before freezing in liquid nitrogen. For experiments designed to locate putative Mg 2+ binding sites, crystallization of the apo receptor was performed with 50 mM MnCl 2 substituted in place of 50 mM MgCl 2 .
TNP-ATP soaking experiments. TNP-ATP was added to the drop of apo hP2X 3 -MFC slow receptor crystals to a final concentration of 1-2 mM and allowed to soak for 24 h before harvesting. Cryo-protection was performed by increasing the concentration of PEG 400 to 36% before freezing in liquid nitrogen. Crystallization of A-317491-bound state. Purified hP2X 3 -MFC slow obtained from dialysed membranes was supplemented with 3-4 mM A-317491 and set up in reservoir buffer containing 20% PEG 400, 100 mM glycine, pH 8.5 and 150 mM MgCl 2 . Crystals were cryo-protected by increasing the concentration of PEG 400 to 36% before freezing in liquid nitrogen. Crystallization of ATP-bound closed pore state. Purified hP2X 3 -MFC was supplemented with 0.25 mM TNP-ATP and set up in reservoir buffer containing 21% PEG 400, 100 mM Tris, pH 8.0, 325 mM sodium acetate, and 100 mM NaCl. Crystals were cryo-protected by transfer to well buffer supplemented with 25% ethylene glycol before freezing in liquid nitrogen. Under these conditions, TNP-ATP acted as an additive to facilitate crystallization of hP2X 3 bound to endogenous ATP. Exposing these crystals to 1 mM TNP-ATP resulted in their destruction but exposing them to 1 mM ATP or 2-methylthio-ATP kept them intact. No crystals could be grown using TNP-ATP co-crystallization with apo protein where the endogenous ATP had been removed by extensive dialysis (see above). 2-methylthio-ATP soaking experiments. Crystals of hP2X 3 -MFC grown under the ATP-bound, closed pore conditions were subjected to soaking with either 2-methylthio ATP or TNP-ATP. Crystals were harvested from their drops individually using loops and transferred to a 5-μ l drop of reservoir solution plus either 0.5 mM TNP-ATP or 0.5 mM 2-methylthio-ATP and 0.5 mM C12M. The crystals were allowed to soak in the drop for 48 h and crystals that survived were transferred to a second 5-μ l drop of reservoir solution with 0.5 mM soaking ligand and 0.5 mM C12M. The crystals were then harvested after 96 h by transfer into reservoir buffer with 0.5 mM ligand, 0.5 mM C12M and 25% ethylene glycol as the cryo-protectant. . For both the TNP-ATP soaked structure and the A-317491-bound structure, diffraction data were further processed by micro-diffraction data assembly analysis 53 . For the apo state structure, anisotropic scaling was performed with F/σ F = 3.0 as the cutoff criterion using the UCLA anisotropy server 54 . All structures were solved by molecular replacement using the PHASER package 55, 56 . The first hP2X 3 structure solved in this study used the apo state zfP2X 4 structure as the search model 29 . All subsequent structures, however, used hP2X 3 models as search models. Models were built and refined using tools in the CCP4 57 , COOT 58 , and PHENIX 59 packages. Stereochemistry was evaluated using MolProbity 60 . The three anomalous diffraction data sets were collected at wavelengths near the X-ray absorption edges of the f′ ′ of the element (Extended Data Table 2 ). The Calculate Maps utility of PHENIX was used to calculate the anomalous maps with high-resolution cut-offs of 4.0 Å, 4.0 Å, and 3.8 Å for the sulfur, manganese and caesium data, respectively. Two-electrode voltage clamp. RNAs encoding hP2X 3 -MFC and hP2X 3 -MFC slow were transcribed from pCDNA3.1x plasmids using the mMessage mMachine T7 Ultra kit. Xenopus oocytes were then injected with 5-10 ng RNA and incubated at 18 °C for 1-2 days in a solution containing 96 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , 5 mM HEPES, pH 7.5 and 250 μ g/ml amikacin. Current recordings were made in a buffer containing 90 mM NaCl, 1 mM KCl, 2 mM MgCl 2 , and 10 mM HEPES, pH 7.4. Recording electrode pipettes (1-2.5 MΩ ) were filled with 3 M KCl. Oocytes were voltage clamped at − 60 mV. Traces were recorded with ATP at 1 μ M concentration with or without co-application of antagonist, either TNP-ATP or A-317491, at 2 μ M. Analogue data were filtered at 50 Hz and digitized at > 1 kHz. The Axoclamp 2B amplifier and pClamp 10 software were used for data acquisition. Radioligand-binding experiments. Scintillation proximity assays (SPA) were performed on detergent-solubilized hP2X 3 -MFC and hP2X 3 -MFC slow receptors 34 , purified without tag cleavage from dialysed membranes. ATP affinity experiments were carried out using polyvinyltoluene copper (PVT-Cu) beads at 0.5 mg/ml, 10 nM GFP-His8-hP2X 3 protein in PBS buffer, pH 8.0, 0.3% BSA, and 0.15 mM C12M. Counts were recorded with increasing concentration of cold competitive antagonist. The SPA signal was counted at various time points after gentle agitation (15 min) at room temperature. Assay plates were read using a MicroBeta counter. Data were fitted using a standard single site competition equation, and K i values were calculated from the IC 50 values using the Cheng-Prusoff equation. All data points are from triplicate experiments. Molecular dynamics simulations. Simulation setup. The open state of hP2X 3 was used as the initial structure for the simulations. Protonation states of the titratable residues were assigned based on pK a calculations using PROPKA 3.1 [61] [62] [63] at pH 7. Accordingly, all the glutamate and aspartate residues were modelled in their default (unprotonated) form. Protein was placed into a POPC lipid bilayer using the replacement method in CHARMM-GUI and solvated 64 . Na + and Cl − ions were added to neutralize the system with a net concentration of 100 mM. The system (197,531 atoms) was minimized for 5,000 steps and simulated for 10 ns at 310 K with all heavy atoms of the protein restrained to their crystallographic positions with a spring constant of k = 5 kcal/mol/Å 2 . Thereafter, the restraints on the side chains were removed and the system was simulated for an additional 10 ns with only the C α atoms restrained at a spring constant of k = 5 kcal/mol/Å 2 . Finally, all the restraints were removed and the system was simulated for 500 ns. The final system had dimensions of 110 Å × 110 Å × 153 Å. Simulation protocol. All the simulations were performed with NAMD 2.9 65 using CHARMM27 force field for proteins with ϕ /ψ cross term map (CMAP) corrections 66, 67 and CHARMM36 all-atom additive parameters for lipids 68 . Water was modelled as TIP3P 69 . All simulations were performed using the NPT ensemble with periodic boundary conditions. Temperature was maintained at 310 K using Langevin dynamics 70 with a damping coefficient of 0.5 ps
. Pressure was kept at 1 atm using the Nosé-Hoover Langevin piston method 70, 71 with a piston period of 100 fs and a piston decay of 50 fs. Short-range interactions were cut off at 12 Å with a switching applied at 10 Å. Long-range electrostatic forces were calculated using the particle mesh Ewald (PME) 72 method at a grid density of > 1 Å −3 . Bonded, non-bonded, and PME calculations were performed at 2-, 2-, and 4-fs intervals, respectively. All restraints were in harmonic form with a spring constant of k = 5 kcal/mol/Å 2 . Minimizations employed a conjugate gradient algorithm. Simulation under an electric potential. In order to achieve more efficient sampling of the hydrated pathways identified at the protein-lipid interface during the equilibrium simulations, and to assess their potential role as an ion translocation pathway, an independent simulation was set up in which a constant electric potential was applied across the lipid bilayer by imposing a uniform electric field E on all atoms of the system along the membrane normal (z-axis). The imposed electric field resulted in a membrane potential difference of 1 V (calculated as E·l z , where E is the magnitude of the electric field and l z is the length of the periodic cell along the membrane normal). The starting point for the membrane potential simulation was a snapshot at t = 200 ns from the equilibrium simulation, which was then simulated under electric potential for an additional 200 ns.
